Immune stimulation by phosphorothioate oligonucleotide analogs
AssigneeColey Pharmaceutical Group, Inc.
InventorsStephen L. Hutcherson, Josephine M. Glover
Life of this patent
Estimating the term…
Loading patent…
AssigneeColey Pharmaceutical Group, Inc.
InventorsStephen L. Hutcherson, Josephine M. Glover
Estimating the term…
Methods of stimulating a local immune response in selected cells or tissues employing immunopotentiating oligonucleotide analogs having at least one phosphorothioate internucleotide bond are provided. Methods of enhancing the efficacy of a therapeutic treatment by stimulating a local immune response in selected cells or tissues employing oligonucleotide analogs having at least one phosphorothioate bond are also provided. The oligonucleotide analogs may have antisense efficacy in addition to immunopotentiating activity. Methods of modulating cytokine release in skin cells and immunopotentiators which include oligonucleotide analogs having at least one phosphorothioate bond capable of eliciting a local inflammatory response are also provided.
A method for treating prophylactically a human to stimulate a cell-mediated immune response comprising:
A method for treating a human who has cancer comprising:
A method for treating a human who has an infection comprising:
A method for treating a human having surgery comprising:
A method for treating therapeutically a human, comprising:
A method of enhancing the efficacy of a therapeutic or prophylactic treatment for a human subject by stimulating a cell-mediated immune response, comprising:
Dependencies are inferred from the claim text.